295 related articles for article (PubMed ID: 28162931)
1. Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial.
Dobbels F; De Bleser L; Berben L; Kristanto P; Dupont L; Nevens F; Vanhaecke J; Verleden G; De Geest S
J Heart Lung Transplant; 2017 May; 36(5):499-508. PubMed ID: 28162931
[TBL] [Abstract][Full Text] [Related]
2. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
Foster BJ; Pai ALH; Zelikovsky N; Amaral S; Bell L; Dharnidharka VR; Hebert D; Holly C; Knauper B; Matsell D; Phan V; Rogers R; Smith JM; Zhao H; Furth SL
Am J Kidney Dis; 2018 Jul; 72(1):30-41. PubMed ID: 29602631
[TBL] [Abstract][Full Text] [Related]
4. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen.
Eberlin M; Otto G; Krämer I
Transplant Proc; 2013; 45(6):2314-20. PubMed ID: 23726723
[TBL] [Abstract][Full Text] [Related]
5. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.
McGillicuddy JW; Chandler JL; Sox LR; Taber DJ
Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922
[TBL] [Abstract][Full Text] [Related]
7. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
[TBL] [Abstract][Full Text] [Related]
9. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence.
Godinas L; Dobbels F; Hulst L; Verbeeck I; De Coninck I; Berrevoets P; Schaevers V; Yserbyt J; Dupont LJ; Verleden SE; Vanaudenaerde BM; Ceulemans LJ; Van Raemdonck DE; Neyrinck A; Verleden GM; Vos R
J Heart Lung Transplant; 2021 Jun; 40(6):467-477. PubMed ID: 33840608
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial.
Jung HY; Seong SJ; Choi JY; Cho JH; Park SH; Kim CD; Yoon YR; Kim HK; Huh S; Yoon SH; Lee JS; Kim YL
Trials; 2017 Oct; 18(1):480. PubMed ID: 29037222
[TBL] [Abstract][Full Text] [Related]
11. Non-adherence and graft failure in adult liver transplant recipients.
Lieber SR; Volk ML
Dig Dis Sci; 2013 Mar; 58(3):824-34. PubMed ID: 23053889
[TBL] [Abstract][Full Text] [Related]
12. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients.
Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD
Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029
[TBL] [Abstract][Full Text] [Related]
13. Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.
Leader A; Benyamini N; Gafter-Gvili A; Dreyer J; Calvarysky B; Amitai A; Yarchovsky-Dolberg O; Sharf G; Tousset E; Caspi O; Ellis M; Levi I; De Geest S; Raanani P
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e449-e461. PubMed ID: 30030034
[TBL] [Abstract][Full Text] [Related]
14. Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.
Paterson TSE; Demian M; Shapiro RJ; Loken Thornton W
Can J Kidney Health Dis; 2019; 6():2054358119867993. PubMed ID: 31452902
[TBL] [Abstract][Full Text] [Related]
15. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
16. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol.
Mansell H; Rosaasen N; West-Thielke P; Wichart J; Daley C; Mainra R; Shoker A; Liu J; Blackburn D
BMJ Open; 2019 Mar; 9(3):e025495. PubMed ID: 30872550
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific immunoglobulin replacement in lung transplantation recipients with hypogammaglobulinemia: a cohort study taking into account propensity score and immortal time bias.
Claustre J; Quétant S; Camara B; France M; Schummer G; Bedouch P; Pavese P; Saint Raymond C; Bardy B; Masson D; Roth H; Pison C;
Transplantation; 2015 Feb; 99(2):444-50. PubMed ID: 25099705
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial.
Amado Guirado E; Pujol Ribera E; Pacheco Huergo V; Borras JM;
Gac Sanit; 2011; 25(1):62-7. PubMed ID: 21354671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
